文献速递质量管理与危急值临床生化临床免疫

三级医院临床实验室全自动化流水线的经济学评价

Economic Evaluation of Total Laboratory Automation in the Clinical Laboratory of a Tertiary Care Hospital.
PubMed 文献 · Ann Lab Med · 2022-01-01

该研究对比某三级医院检验科全自动化流水线(TLA)启用前后临床化学与免疫检测表现,采用实验室信息系统数据评估临床效果、折旧数据核算成本。结果显示四项关键绩效指标均改善,仅计人力成本节约时预计投资回收期为4.75年,认为TLA投资值得。

要点

  • TLA启用后平均周转时间(TAT)下降6.1%,第99百分位TAT下降13.3%。
  • TAT变异系数下降70.0%,加权试管接触时刻(wTTM)改善77.6%。
  • 仅计人力成本节约时,初始投资预计4.75年回收。

核心结论

  • TLA可显著提升实验室绩效,投资回收期相对较短,长期可降低医院总费用,资本投资被认为值得。

研究设计与样本

  • 单中心前后对比研究,比较某三级医院检验科TLA启用前后临床化学与免疫检测表现。
  • 临床效果采用实验室信息系统数据测量,TLA成本采用折旧数据计算。

主要发现

  • 平均周转时间(TAT)下降6.1%,第99百分位TAT下降13.3%。
  • TAT变异系数(CV)下降70.0%,加权试管接触时刻(wTTM)改善77.6%。
  • 增量成本效果比分析中,wTTM被用作最具成本效果的性能指标。
  • 仅考虑人力成本节约时,预计初始投资回收期为4.75年。

临床怎么用

  • 可参考TAT均值、第99百分位TAT、TAT变异系数与wTTM四项指标评估TLA启用前后的实验室绩效变化。
  • 评估TLA投资回报时可结合人力成本节约测算预计回收期。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Total laboratory automation (TLA) is an innovation in laboratory technology; however, the high up-front costs restrict its widespread adoption. To examine whether the capital investment for TLA is worthwhile, we analyzed its clinical- and cost-effectiveness for the expected payback period. METHODS: Clinical chemistry tests and immunoassays performed in the clinical laboratory of a tertiary care hospital were divided into a post-TLA group, including 1,182,419 tests performed during December 2019, and a pre-TLA group, including 1,151,501 tests performed during December 2018. Laboratory information system data were used to measure clinical effectiveness, and depreciation data were used to calculate TLA costs. RESULTS: Laboratory performance improved after TLA adoption in all four key performance indicators: mean turn-around time (TAT), representing the timeliness of result reporting, decreased by 6.1%; the 99th percentile of TAT, representing the outlier rate, decreased by 13.3%; the TAT CV, representing predictability, decreased by 70.0%; and weighted tube touch moment (wTTM), representing staff safety, improved by 77.6%. Based on these effectiveness results, economic evaluation was performed using two approaches. First, the incremental cost-effectiveness ratio and wTTM were used as the most cost-effective performance indicators. Second, the expected payback period was calculated. Considering only staff cost reduction, it was anticipated that 4.75 yrs would be needed to payback the initial investment. CONCLUSIONS: TLA can significantly enhance laboratory performance, has a relatively quick payback period, and can reduce total hospital expenses in the long term. Therefore, the capital investment for TLA adoption is considered to be worthwhile.

来源:Ann Lab Med,查看原文。版权归原作者所有。

引用

  1. Kim K, Lee SG, Kim TH, et al. Economic Evaluation of Total Laboratory Automation in the Clinical Laboratory of a Tertiary Care Hospital. Ann Lab Med. 2022. PMID: 34374353. doi:10.3343/alm.2022.42.1.89

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。